Suchergebnisse - "Safra, Tamar"

PubPharm (19)

1

Efficacy and safety of rucaparib treatment in patients with BRCA-mutated, relapsed ovarian cancer : final results from Study 10

enthalten in: British journal of cancer | 2023

von Kristeleit, R. | Drew, Y. | Oza, A. | +13

2

Pembrolizumab in Patients With Microsatellite Instability-High Advanced Endometrial Cancer : Results From the KEYNOTE-158 Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2022

von O'Malley, D. | Bariani, G. | Cassier, P. | +11

3

Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy

enthalten in: British journal of cancer | 2018

von Friedlander, M. | Matulonis, U. | Gourley, C. | +18

4

Everolimus Plus Letrozole for Treatment of Patients With HR+, HER2- Advanced Breast Cancer Progressing on Endocrine Therapy : An Open-label, Phase II Trial

enthalten in: Clinical breast cancer | 2018

von Safra, T. | Kaufman, B. | Kadouri, L. | +5

5

A Phase I-II Study of the Oral PARP Inhibitor Rucaparib in Patients with Germline BRCA1/2-Mutated Ovarian Carcinoma or Other Solid Tumors

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2017

von Kristeleit, R. | Shapiro, G. | Burris, H. | +17

6

Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy : an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial

enthalten in: The Lancet. Oncology | 2016

von Ledermann, J. | Harter, P. | Gourley, C. | +15

CommentIn: Lancet Oncol. 2016 Nov;17 (11):1474-1475. - PMID 27819228

7

Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancer

enthalten in: British journal of cancer | 2016

von Ledermann, J. | Harter, P. | Gourley, C. | +14

8

Olaparib maintenance therapy in patients with platinum-sensitive, relapsed serous ovarian cancer and a BRCA mutation : Overall survival adjusted for postprogression poly(adenosine diphosphate ribose) polymerase inhibitor therapy

enthalten in: Cancer | 2016

von Matulonis, U. | Harter, P. | Gourley, C. | +13

9

Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer : a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial

enthalten in: The Lancet. Oncology | 2014

von Ledermann, J. | Harter, P. | Gourley, C. | +15

CommentIn: Lancet Oncol. 2014 Jul;15(8):783-5. - PMID 24882435

10

Weekly topotecan for recurrent ovarian, fallopian tube and primary peritoneal carcinoma : tolerability and efficacy study--the Israeli experience

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2013

von Safra, T. | Berman, T. | Yachnin, A. | +6